Overview of regular dialysis treatment in Japan (as of 31 December 2009). - Wikidata - awgldk - TriplyDB

Overview of regular dialysis treatment in Japan (as of 31 December 2009).

Overview of regular dialysis treatment in Japan (as of 31 December 2009).

http://www.wikidata.org/entity/Q43610757

about

Oral adsorbents for preventing or delaying the progression of chronic kidney disease Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan.The influence of a single nucleotide polymorphism within CNDP1 on susceptibility to diabetic nephropathy in Japanese women with type 2 diabetes.Magnesium modifies the cardiovascular mortality risk associated with hyperphosphatemia in patients undergoing hemodialysis: a cohort study.Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients.Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial High-Flux Hemodialysis Benefits Hemodialysis Patients by Reducing Serum FGF-23 Levels and Reducing Vascular Calcification.Correlation of hippocampal atrophy with hyperhomocysteinemia in hemodialysis patients: An exploratory pilot study.Nephrology for the people: Presidential Address at the 42nd Regional Meeting of the Japanese Society of Nephrology in Okinawa 2012.Worldwide, mortality risk is high soon after initiation of hemodialysis.Hepcidin is a potential regulator of iron status in chronic kidney disease.Clinical benefits of predilution on-line hemodiafiltration.Prevalence and incidence of chronic kidney disease stage G5 in Japan.The necessity and effectiveness of mineralocorticoid receptor antagonist in the treatment of diabetic nephropathy.A case of disseminated tuberculosis after the initiation of hemodialysis.Anticipated increase in the number of patients who require dialysis treatment among the aging population of Japan.Evaluation of Parathyroidectomy for Secondary and Tertiary Hyperparathyroidism by the Parathyroid Surgeons' Society of Japan.An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2013).Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study.Peritoneal Dialysis Registry With 2013 Survey Report.Effect of dialyzer membrane materials on survival in chronic hemodialysis patients: Results from the annual survey of the Japanese Nationwide Dialysis Registry.Prevalence of Fabry disease in dialysis patients: Japan Fabry disease screening study (J-FAST).Heart rate variability predicts mortality in peritoneal dialysis patients.Survival after arterial embolization therapy in patients with polycystic kidney and liver disease.Withdrawal from Dialysis and Palliative Care for Severely Ill Dialysis Patients in terms of Patient-Centered Medicine.Study of electrical power facilities and measures for planned outages in Japanese hemodialysis clinics after the Great East Japan Earthquake.Stiffness parameter β as a predictor of the 4-year all-cause mortality of chronic hemodialysis patients.Overview of regular dialysis treatment in Japan (as of 31 December 2011).Views of Japanese patients on the advantages and disadvantages of hemodialysis and peritoneal dialysis.Effects of valsartan on progression of kidney disease in Japanese hypertensive patients with advanced, predialysis, chronic kidney disease: Kanagawa Valsartan Trial (KVT).Efficacy of N-terminal pro-brain natriuretic peptide digit number for screening of cardiac disease in new haemodialysis patients.Interactive Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers or Their Combination on Survival of Hemodialysis Patients.Association between dialysis treatment and cognitive decline: A study from the Project in Sado for Total Health (PROST), Japan.Magnesium and Risk of Hip Fracture among Patients Undergoing Hemodialysis.Evaluation of the Predictive Value of the Serum Calcium-Magnesium Ratio for All-Cause and Cardiovascular Mortality in Incident Dialysis Patients.Clinical factors associated with serum copper levels and potential effect of sevelamer in hemodialysis patients.Sonographic detection of a radiolucent object in dialysis vascular access.Comparison of prognosis between patients with renal cell carcinoma on hemodialysis and those with renal cell carcinoma in the general population.An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2010)

P2860

Q24193105-19278098-0B71-47FB-A431-06683F746373 Q34549739-B62DB628-AEEB-4E64-88A6-9AAC5CB1A961 Q34559105-3E9812DC-7E71-4FF3-A588-1D66DE0B612B Q34784711-00CDB44F-9F1E-4064-9973-D829AC6B0878 Q35940980-E7B48190-C623-4E51-B8F9-2C8D36D6EC1C Q36079520-A24222B1-14E0-4CA4-A80F-8594C4D3DD50 Q36287699-787BCCA6-8C42-4E36-B81E-39E8A1F010AC Q36342152-75FC6809-C93E-40A0-8B2B-0F08A9073E19 Q37115569-CAA656C2-757C-4F71-AF1B-ADF33AB5E943 Q37424629-0F6878EC-B9E6-46F1-8261-F81B0A39033A Q38078962-CD9456E9-C5D8-473C-981D-88A4918DB37D Q38087137-A4A3A2F5-2702-4311-99DE-513C44264D8A Q38211367-F08937D7-1840-44C5-A520-928B70CF17B9 Q38374536-28F33916-3925-411A-BB45-70C63981ECFB Q38783507-DEFE35C9-EF5C-4D4E-B02F-7FC34800AC8B Q39067559-71F0E493-B8AE-4DDA-80A6-7BB89D7FCC2E Q39995286-7ED99248-A5CB-4FC8-91E4-62F01BA25316 Q40106842-9BB788EF-999F-4CC3-81B8-78679C2C6EB8 Q40252422-0CAC51D2-ACBA-4E60-A922-02B13A11A275 Q40391412-5728A5EA-9785-4C95-9CEB-209FE90BD74B Q41072062-47FBA259-83BA-41C0-9FCA-A4702A985BC2 Q41562385-39CCE455-D203-4D25-9CD7-A2CF7E41BDB1 Q41629316-9CDA09F7-B644-4EE2-9699-9D171039E664 Q41735472-78F4E8EE-B5D2-4C2B-A378-D32AA2A27A3C Q41914385-96E0B56E-E7B4-4888-BEAA-9A08307A1C17 Q41971272-CDED4889-D353-46C7-813E-7817697AFEEE Q44326203-26E3A9AD-E519-4FF1-95CC-72C0E28C326C Q44632924-764B7B14-FB62-461D-AFA6-55CA378EEAB7 Q45241059-27BCC81D-40EC-4EB6-8689-513458EE7930 Q45423869-FD67BA37-2627-418A-BFE1-29D293C81037 Q45536640-7EC87EFD-654E-419A-8986-3BA211F92842 Q47434892-9843DA76-4A37-4D67-AAC2-67BC5F18F2C1 Q47872581-513A0F66-B271-461F-ABFE-1E7B7445883E Q48207264-29DED9BE-4312-49FE-8D97-6E6A218B1627 Q49987850-DEB471C2-030D-4EB2-B7C6-E37318E75A06 Q51332971-D96D154F-8DC1-4A29-8962-057FBAC7651C Q53514694-E2EFA091-97D3-4CC1-97B2-D25D96F2E677 Q53586772-01ABC6F6-02AD-4852-94A0-CC1289B517FB Q57623222-AC0DE700-0D80-4BF3-AB30-E61871C7A7E2

P2860

Overview of regular dialysis treatment in Japan (as of 31 December 2009).

http://www.wikidata.org/entity/Q43610757

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

Overview of regular dialysis treatment in Japan (as of 31 December 2009).

@en

type

label

Overview of regular dialysis treatment in Japan (as of 31 December 2009).

@en

prefLabel

Overview of regular dialysis treatment in Japan (as of 31 December 2009).

@en

P1433

Q43610757-9283B2F5-8C59-4ED0-8231-BE5E459DFD2C

P1476

Q43610757-564C7719-E843-404D-83AD-17C55B3868CF

P2093

Q43610757-0C493BFE-4999-4913-92FB-E6CE00E4F40D

Q43610757-0EE8F4E3-19D3-4CF3-AE7C-FFFE8BE452FF

Q43610757-1E65C4D1-19EA-41BE-86A8-50C3E09E99B5

Q43610757-1F3EE0A3-8D54-449B-9ABC-9D08A0D3B7DC

Q43610757-345418AF-ED29-4DD4-9CFD-B20539A57EE7

Q43610757-47EC4071-ECAA-41C9-9BFD-C253EAD4A98F

Q43610757-4A98D191-74C9-4BF0-9253-8BFC5E98B4DF

Q43610757-4E19F8F9-C84E-4BA1-B0ED-23988DDFD8D9

Q43610757-5B0D0591-23FD-4267-A979-7D0760A7BE79

Q43610757-5CCC049C-3960-439A-819C-71E3B44B97FD

P2860

Q43610757-11454BE9-1E33-44CA-8739-040D116B163F

Q43610757-35134C4E-5327-4A89-8103-1A51E3A9E115

Q43610757-38F41A1E-7F19-4D37-AD52-05DA7B8D05D2

Q43610757-444BD70B-0CA6-4A72-895E-A9A56FBC43C0

Q43610757-95752B65-7614-49D0-9C5F-0BE8FF838325

P304

Q43610757-ECF63775-244C-4DF8-A200-D828CDB6B0E1

P31

Q43610757-2568B831-8F7B-4714-A67D-4C61F2CD555F

P356

Q43610757-6E31D39E-C93A-42D0-9FE4-988DC51153DE

P433

Q43610757-3847C98A-A70E-4B85-BF18-A6E38F850A62

P478

Q43610757-1C14F66E-6A9D-4598-ABB6-6007409E8533

P50

Q43610757-2E491670-49E9-464A-8C8D-CBCB37638266

Q43610757-41027FAD-4EDE-49CC-8481-654D479AD6C4

P577

Q43610757-36D34F5E-D8E2-498C-B477-87AADE914431

P5875

Q43610757-EBCE4E8B-276A-48F3-961D-E98383B77A94

P698

Q43610757-19997273-0C7E-4063-9707-464AC33C6A91

P921

Q43610757-6FC59D4E-3160-4057-A8FF-32A7E447F120

P356

J.1744-9987.2011.01050.X

P1433

Therapeutic Apheresis and Dialysis

P1476

Overview of regular dialysis treatment in Japan (as of 31 December 2009).

@en

P2093

Atsushi Wada

http://www.w3.org/2001/XMLSchema#string

Hidetomo Nakamoto

http://www.w3.org/2001/XMLSchema#string

Hiroshi Nishi

http://www.w3.org/2001/XMLSchema#string

Ikuto Masakane

http://www.w3.org/2001/XMLSchema#string

Junichiro James Kazama

http://www.w3.org/2001/XMLSchema#string

Kazuyuki Suzuki

http://www.w3.org/2001/XMLSchema#string

Kenji Tsuchida

http://www.w3.org/2001/XMLSchema#string

Kenji Wakai

http://www.w3.org/2001/XMLSchema#string

Kunihiro Yamagata

http://www.w3.org/2001/XMLSchema#string

Kunitoshi Iseki

http://www.w3.org/2001/XMLSchema#string

P2860

An overview of regular dialysis treatment in Japan (as of 31 December 2002).

Overview of regular dialysis treatment in Japan (as of 31 December 2008).

An overview of regular dialysis treatment in Japan (as of 31 December 2007).

Overview of regular dialysis treatment in Japan as of 31 December 2006.

Standard on microbiological management of fluids for hemodialysis and related therapies by the Japanese Society for Dialysis Therapy 2008.

P304

11-53

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1744-9987.2011.01050.X

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Takeshi Hasegawa

Yoshiharu Tsubakihara

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221750395

http://www.w3.org/2001/XMLSchema#string

P698

22248195

http://www.w3.org/2001/XMLSchema#string

P921